SCHEMBL221883

SCHEMBL221883

C1=CN=CNC=C1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL6298787 0.97
Bromide SCHEMBL28959975 0.97
SCHEMBL28297823 0.97
SCHEMBL30672672 0.87
SCHEMBL30434166 0.84
SCHEMBL28379045 0.83
SCHEMBL31658718 0.80
Pyrene SCHEMBL27902770 0.78 ALDH1A1 (0.42)
SCHEMBL31658721 0.73
SCHEMBL28065111 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1255 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4249468-B1 A METHOD FOR SYNTHESIS OF HALIDE SALTS SOLAVENI GMBH (DE) 2025-05-07 EP claimed
WO-2025076059-A1 ROCAGLATE DERIVATIVES AND USES THEREOF TRUSTEES OF BOSTON UNIVERSITY (US) 2025-04-10 WO claimed
CN-116003418-A CRBN E3 ligase ligand compound, protein degradation agent developed based on ligand compound and application thereof 标新生物医药科技(上海)有限公司 2023-04-25 CN claimed
WO-2023036995-A1 ALKYNYLCARBINOLS WITH HIGH CYTOTOXICITY CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (FR) 2023-03-16 WO claimed
EP-4126229-A1 MTORC1 MODULATORS AND USES THEREOF Aeovian Pharmaceuticals, Inc. (US) 2023-02-08 EP claimed
CN-115677671-A Quinoxaline derivative and application thereof 北京八亿时空液晶科技股份有限公司 2023-02-03 CN claimed
CN-115636819-A Luminescent material, application thereof and organic electroluminescent device comprising luminescent material 清华大学 2023-01-24 CN claimed
CN-112294771-B Quick-release pharmaceutical composition 生达化学制药股份有限公司 2023-01-17 CN claimed
CN-115197251-A Organic compound and application thereof 清华大学 2022-10-18 CN claimed
CN-110729418-B Organic electroluminescent device and display device 昆山国显光电有限公司 2022-06-03 CN claimed
EP-0831818-A2 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-GAMMA, AND METHODS FOR THE USE THEREOF THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1998-04-01 EP claimed
WO-1996040128-A2 MODULATORS OF PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR-GAMMA, AND METHODS FOR THE USE THEREOF THE SALK INSTITUTE FOR BIOLOGICAL STUDIES (US) 1996-12-19 WO claimed
WO-1994017075-A1 DIAZEPIN DERIVATIVES AND ANTIVIRAL COMPOSITIONS A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.R.L. (IT) 1994-08-04 WO claimed
EP-0465369-B1 N-substituted derivatives of alpha-mercapto alkylamines, process for their preparation and intermediates obtained, their use as medicaments and compositions containing them ROUSSEL UCLAF (FR) 1994-04-13 EP claimed
EP-0213326-B1 2,5-DIMETHYL PYRROLE DERIVATIVES, THEIR PREPARATION AND THEIR USE CASSELLA Aktiengesellschaft (DE) 1991-03-06 EP claimed
EP-0183848-B1 POLYAZAHETEROCYCLIC DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND PHARMACEUTICAL COMPOSITION Yoshitomi Pharmaceutical Industries, Ltd. (JP) 1990-09-12 EP claimed
US-4705853-A ANTIHISTAMINES A. H. ROBINS COMPANY, INC. (US) 1987-11-10 US claimed
EP-0042279-B1 N-ARYL-N'((1,4,5,6-TETRAHYDROPYRIMIDIN-2-YL) OR (4,5,6,7-TETRAHYDRO-1-H-1, 3-DIAZEPIN-2-YL)UREAS FOR INTESTINAL DISORDERS AND AS ANTIHYPERTENSIVES McNeilab, Inc. (US) 1985-11-13 EP claimed
EP-0041359-A1 Process for the preparation of heterocyclylalkyl guanidines; intermediates and their preparation SMITH KLINE & FRENCH LABORATORIES LIMITED (GB) 1981-12-09 EP claimed
EP-0001585-A1 Piperazino-pyrrolobenzodiazepines, methods for their preparation and pharmaceutical compositions containing them CIBA-GEIGY AG (CH) 1979-05-02 EP claimed